Investigator

Andrew J. Mungall

Group Leader/Staff Scientist II · BC Cancer Agency, Canada's Michael Smith Genome Sciences Centre

Research Interests

AJMAndrew J. Mungall
Papers(1)
Rearrangements of vir…
Collaborators(10)
Glenn ChangInanc BirolJanet S. RaderKa Ming NipKieran O'NeillLuka CulibrkMarco A. MarraMarissa IdenMichelle NgShirng-Wern Tsaih
Institutions(2)
Canadas Michael Smith…Medical College of Wi…

Papers

Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation

Human papillomavirus (HPV) integration has been implicated in transforming HPV infection into cancer. To resolve genome dysregulation associated with HPV integration, we performed Oxford Nanopore Technologies long-read sequencing on 72 cervical cancer genomes from a Ugandan data set that was previously characterized using short-read sequencing. We find recurrent structural rearrangement patterns at HPV integration events, which we categorize as del(etion)-like, dup(lication)-like, translocation, multi-breakpoint, or repeat region integrations. Integrations involving amplified HPV–human concatemers, particularly multi-breakpoint events, frequently harbor heterogeneous forms and copy numbers of the viral genome. Transcriptionally active integrants are characterized by unmethylated regions in both the viral and human genomes downstream from the viral transcription start site, resulting in HPV–human fusion transcripts. In contrast, integrants without evidence of expression lack consistent methylation patterns. Furthermore, whereas transcriptional dysregulation is limited to genes within 200 kb of an HPV integrant, dysregulation of the human epigenome in the form of allelic differentially methylated regions affects megabase expanses of the genome, irrespective of the integrant's transcriptional status. By elucidating the structural, epigenetic, and allele-specific impacts of HPV integration, we provide insight into the role of integrated HPV in cervical cancer.

251Works
1Papers
14Collaborators
Biomarkers, TumorNeoplasmsPrognosisPancreatic NeoplasmsCarcinoma, Pancreatic DuctalNeoplasm GradingNeoplasm Recurrence, LocalCell Line, Tumor

Positions

2008–

Group Leader/Staff Scientist II

BC Cancer Agency · Canada's Michael Smith Genome Sciences Centre

1993–

Project Leader

Wellcome Trust Sanger Institute

Education

2007

PhD

Wellcome Trust Sanger Institute · Human Genetics

2007

PhD

Open University

1992

BSc (Hons)

University of the West of England · Applied Biological Sciences